CD274 and malignant peripheral nerve sheath tumor: There are case reports of MPNST patient responses to immune checkpoint therapies28,29 and MPNSTs have also been found to upregulate PD-L1 and lack PD1 expression, suggesting a mechanism for immune evasion that could be targeted by checkpoint inhibitors30.